期刊文献+

系统性红斑狼疮患者外周血CD4^+CD39^+T细胞中FOXP3蛋白的表达及糖皮质激素对其影响 被引量:2

Expression of FOXP3 in CD4 ^+ CD39 ^+ T cells of patients with systemic lupus erythematosus and dynamic observation of treatment with glucocorticoid
原文传递
导出
摘要 目的研究系统性红斑狼疮(SLE)患者外周血CD4^+CD39^+T细胞中FOXP3蛋白的表达情况,以及糖皮质激素治疗的影响。方法采用流式细胞术检测47例SLE患者(其中29例为初发未经治疗的活动期SLE)和22名正常人外周血CD4^+CD25^+CD39^+T细胞、CD4^+CD25^+FOXP3^+T细胞及CIM^+CD39^+FOXP3^+T细胞百分率以及FOXP3蛋白的表达,分析3组细胞之间的相关性及糖皮质激素治疗的影响。结果SLE活动组、缓解组、正常对照组外周血CD4^+CD25^+CD39^+T细胞百分率分别为(1.3±0.5)%、(1.9±0.8)%、(2.3±1.0)%,该群细胞在SLE活动组中的表达水平低于缓解组和正常对照组(均P〈0.05),而在后2组之间差异无统计学意义(P〉0.05);SLE活动组中CD4^+CD25^+、CD4^+CD25^high及CD4^+CD39^+T细胞表达的FOXP3蛋白百分率分别为(45±12)%、(65±14)%、(70±14)%,FOXP3蛋白在CD4^+CD39^+T细胞和CD4^+CD25^high T细胞中的表达水平明显高于在CD4^+CD25^+T细胞中的表达水平(P〈0.01),而在CD4^+CD39^+T细胞与CD4^+CD25^high T细胞中的表达水平差异均无统计学意义(均P〉0.05)。结论CD39可能是调节性T细胞较好的表面标记,CD39^+Treg细胞表达异常可能参与SLE的发病机制。 Objective To investigate the level of FOXP3 expressed in CD4^ + CD39 ^+ T cells in peripheral blood of patients with systemic lupus erythematosus (SLE) and observe the regulation of glucocorticoid on it . Methods Frequencies of CD4 ^+ CD25 ^+ CD39 + , CD4^ + CD25 ^+ FOXP3^ + and CD4^ + CD39 ^+ FOXP3^ + T cells and levels of FOXP3 protein were analyzed by flow cytometry of 47 SLE patients ( including 29 untreated/active SLE) and 22 healthy controls. Meanwhile, correlations among three groups and influences of glucocorticoid were analyzed. Results Percents of CD4^ + CD25 + CD39 + T cells expressed in active SLE, inactive SLE and healthy controls were ( 1.3 ± 0.5 ) %, ( 1, 9 ±0.8 ) % and (2.3±1.0) % respectively, the level decreased in active SLE compared with inactive SLE and healthy controls P 〈 0.05 in each group, but it had no significant difference between the latter two groups ( P 〉 0.05 ). In active SLE, levels of FOXP3 protein expressed in CD4 ^+ CD25^ + , CD4^+ CD25^high and CD4^+ CD39^+ T ceils were(45 ± 12 ) % , (65 ± 14 ) % and ( 70 ± 14) % respectively. Levels of FOXP3 expressed in CD4 ^+ CD25^ high and CD4^ + CD39 ^+ T cells were higher than that expressed in CD4^ + CD25 ^+ T cells ( P 〈 0. 01 ), while it had no significant difference between CD4^ + CD25^high T cells and CD4 ^+ CD39^ +T cells (P 〉 0.05 ). Conclusions These results demonstrate that CD39 may be a better surface marker of regulatory T cells, and that deficiency of CD39 ^+ Treg cells may play an important role in the pathogenesis of SLE.
出处 《中华医学杂志》 CAS CSCD 北大核心 2009年第23期1636-1638,共3页 National Medical Journal of China
基金 省临床医学重点学科应用技术项目(05A008) 安徽省国际合作项目(07080703022)
关键词 调节性T细胞 红斑狼疮 系统性 流式细胞术 Retulatory T cells Lupus erythematosus,systemic Flow cytometry
  • 相关文献

参考文献9

  • 1Mudd PA,Teague BN,Farris AD.Regulatory T cells and systemic lupus erythematosus.Stand J Immunol,2006,64:211-218.
  • 2Kang HK,Datta SK.Regulatory T cells in Lupus.Int Rey Immunol,2006,25:5-25.
  • 3赵盛楠,孙凌云.糖皮质激素对系统性红斑狼疮CD4^+ Foxp3^+ T细胞水平的影响[J].中华风湿病学杂志,2008,12(3):166-169. 被引量:5
  • 4Hori S,Nomura T,Sakaguchi S.Control of regulatory T cell development by the transcription factor FOXP3.Science,2003,299:1057-1061.
  • 5O'Garra A,Vieira P.Regulatory T cells and mechanisms of immune system control.Nat Med,2004,10:801-805.
  • 6Mizumoto N,Kumamoto T,Robson SC,et al.CD39 is the dominant Langerhans cell associated ecto-NTPDase:modulatory roles in inflammation and immune responsiveness.Nat Med,2002,8:358-365.
  • 7Bours MJ,Swennen EL,Di Virgilio F,et al.Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation.Pharmacol Ther,2006,112:358-404.
  • 8Thiel M,Caldwell CO,Sitkovsky MV.The critical role of adenosine A2A receptors in downregnlation of inflammation and immunity in the pathogenesis of infectious diseases.Microbes Infect,2003,5:515-526.
  • 9Deaglio S,Dwyer KM,Gao W,et al.Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.JEM,2007,204:1257-1265.

二级参考文献15

  • 1张春兵,杨晓帆,王慧娟,张明顺,苏定雷,柯瑶,季晓辉.系统性红斑狼疮患者外周血CD_4^+CD_(25)^+ T细胞亚群的初步研究[J].南京医科大学学报(自然科学版),2004,24(5):455-458. 被引量:10
  • 2李向培,翟志敏,钱龙,李庆,厉小梅,徐静玮,汪国生,王怡平.系统性红斑狼疮患者CD4^+CD25^+调节性T细胞的变化[J].中华风湿病学杂志,2006,10(3):141-144. 被引量:17
  • 3Taylor PA, Noelle R J, Blazar BR. CD4^+CD25^+ immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med, 2001, 193:1311-1318.
  • 4Liu MF, Wang CR, Fung LL, et al. Decreased CD4^+CD25^+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand .J Immunol, 2004, 59: 198-202.
  • 5Crispin JC, Matrinez A, Alcocer-Varela J. Quantification of regulatory T cell in patients with systemic lupus erythematosus. J Autoimmune, 2003, 21: 273-276..
  • 6Alvarado-Sanchez B, Hernandez-Castro B, Portales-Perez D, et al. Regulatory T cells in patients with systemic lupus erythematosus, J Autoimmune, 2006, 27:110-118.
  • 7Trzonkowski P, Szmit E, Mysliwska J, et al. CD4^+CD25^+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence. Clin Immunol, 2006, 119: 307-316.
  • 8La Cave A, Fang C J, Singh RP, et al. Manipulation of immune regulation in systemic lupus erythematosus. Autoimmune Rev, 2005, 4: 515-519.
  • 9Hahn BH, Ebling F, Singh RR, et al. Cellular and molecular mechanisms of regulation of autoantibody production in lupus. Ann NY Acad Sci, 2005, 1051: 433-441.
  • 10Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the de- velopment and function of CD4^+CD25^+ regulatory T cells. Nat Immunol, 2003, 4: 330-336.

共引文献4

同被引文献16

  • 1李向培,翟志敏,钱龙,李庆,厉小梅,徐静玮,汪国生,王怡平.系统性红斑狼疮患者CD4^+CD25^+调节性T细胞的变化[J].中华风湿病学杂志,2006,10(3):141-144. 被引量:17
  • 2Alam MS,Kurtz CC,Rowlett RM,et al.CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and Helicobacter felis-induced gastritis in mice.J Infect Dis,2009,199:494-504.
  • 3Bombardier C,Gladman DD,Urowitz MB,et al.Derivation of the SLEDAI.A disease activity index for lupus patients.The Committee on Prognosis Studies in SLE.Arthritis Rheum,1992,35:630-640.
  • 4Beigi RD,Kertesy SB,Aquilina G,et al.Oxidized ATP (oATP)attenuates proinflammatory signaling via P2 receptor-independent mechanisms.Br J Pharmacol,2003,140:507-519.
  • 5Antonioli L,Fornai M,Colucci R,et al.Pharmacological modulation of adenosine system:novel options for treatment of inflammatory bowel diseases.Inflamm Bowel Dis,2008,14:566-574.
  • 6Haskó G,Linden J,Cronstein B,et al.Adenosine receptors:therapeutic aspects for inflammatory and immune diseases.Nat Rev Drug Discov,2008,7:759-770.
  • 7Bours MJ,Swennen EL,Di Virgilio F,et al.Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation.Pharmacol Ther,2006,112:358-404.
  • 8Bynoe MS,Viret C.Foxp3 + CD4 + T cell-mediated immunosuppression involves extracellular nucleotide catabolism.Trends Immunol,2008,29:99-102.
  • 9Deaglio S,Dwyer KM,Gao W,et al.Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.J Exp Med,2007,204:1257-1265.
  • 10Borsellino G,Kleinewietfeld M,Di Mitri D,et al.Expression of ectonucleotidase CD39 by Foxp3 + Treg cells:hydrolysis of extracellular ATP and immune suppression.Blood,2007,110:1225-1232.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部